AUBO (Beijing) Intelligent Science and Technology Co. Ltd launches first open research publishing platform dedicated to cobots

News
By Martha Attard Gialanze August 3, 2021

As of today, the world’s first open research publishing platform dedicated to the science and technology of collaborative robots is open for submissions.

This new publishing platform, known as Cobot, is a partnership between AUBO (Beijing) Intelligent Science and Technology Co. Ltd and F1000, the open research publishing arm of Taylor & Francis Group. It enables all research outputs to be published open access and will have the benefits of open science practices, such as open and named peer review, that assure quality and transparency.

The publishing platform provides a research communication outlet of innovative technologies for technicians, researchers, scholars and experts, who are working in the field of collaborative robots. Collaborative robots, or “cobots” are robots intended to work side-by-side and in collaboration with human beings. These machines focus on repetitive tasks to help workers focus more on tasks that require problem-solving skills.

 “It’s absolutely a great pleasure to announce the launch of the first academic and technological publishing platform “Cobot”. It’s the honour of AUBO to partner with F1000, the open research publishing arm of Taylor & Francis Group. After nearly 20 years of development, collaborative robots have become an important and active member of the robot family. They combine the efficiency and precision of traditional industrial robots with the compliancy and flexibility of service robots. Their uses are numerous, from intelligent manufacturing to social services, medical care, education, and training, and are now one of the most widely used robot categories. The launch of Cobot is a major milestone in the development of collaborative robotics. It will facilitate the research and applications of the related technologies, and thus will contribute to the prosperity of the robotic world.” – Hongxing Wei, Professor at Beihang University and President of AUBO (Beijing) Intelligent Science and Technology Co. Ltd.

The scope of Cobot includes, but is not limited to, scientific and technical research topics in intelligent robots, artificial intelligence, human-machine collaboration, human-machine integration, machine vision, intelligent sensing, smart materials, and more. This also includes the design, development and testing of collaborative robots and relevant software, as well as case studies focused on their wide-ranging use and applications.  

Along with research articles and case studies, Cobot features a variety of article types including method articles, study protocols, software tools, systematic reviews, data notes, brief reports, and opinion articles.

The platform is now open for submissions: http://collaborative-robot.org/

About F1000

F1000 fosters a culture of innovation to accelerate the reach of knowledge and put it in the hands of those who will shape the future.  

We provide open research publishing solutions and services to organizations such as the European Commission, Wellcome, and the Bill & Melinda Gates Foundation, as well as directly to researchers through our own publishing platform, F1000Research.

F1000 is wholly owned by the Taylor & Francis Group, an Informa Group company.

About AUBO (Beijing) Intelligent Science and Technology Co. Ltd 

AUBO is a leading high-tech corporate engaged in the research, development, production, sales, and integration services of collaborative robots (cobots). In China, AUBO developed the first cobot “AUBO-i5”, which has passed domestic and international technical certifications such as ISO, NRTL, CE, CR, KCs, etc. AUBO is the only Chinese cobot brand that has export qualification. The AUBO cobots have been widely used in smart manufacturing, medical treatment, education, services, etc.  

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.